Pancreatic cancer · 2 regimens
Cost vs Efficacy · 1 point
| Regimen | Biomarker | Cost/cycle ↓ | Cycle | PFS ↕ | OS ↕ | Est. cycles | Course cost ↕ | Evidence |
|---|---|---|---|---|---|---|---|---|
Olaparib monotherapy Variant #01 | BRCA | R 59 224 | 28d | ~7.4 mo | — | ~9 | ~R 533 016 PFS proxy · indirect | 1 |
Best supportive care Partial | — | — | — | — | 7.9 mo | — | — | 2 |
2 of 2 regimens shown